Child and Adolescent Psychiatry and Psychotherapy
Medical Director of the Clinic of Child and Adolescent Psychiatry and Psychotherapy and Deputy Director of the Central Institute of Mental Health (CIMH)
Phone: +49 621 1703-4501
Fax: +49 621 1703-4505
Main Medical Building, 3rd Floor, Room 340
Personal consultant / Research Aide Adviser:
Sabina Millenet, Psychological psychotherapist, Phone: +49 (0)621 1703-4912, e-mail
Main Medical Building, 3rd Floor, Room 341
The department consist of 53 beds with 4 wards. Its mission is to provide state of the art mental health care for the population of Mannheim and the surrounding communities in the Rhine-Neckar County; all child and adolescent psychiatric disorders (n = 450 per year) are treated according to the most innovative quality standards, with the exception of withdrawal treatment for addiction patients. ... Health Care
Since the new appointment of Professor Banaschewski as head of Department and Chair of Child and Adolescent Psychiatry in November 2006, research focuses on ADHD and comorbid disorders, particularly disorders associated with impulse control problems and aggressive behavior. A second clinical and research focus is on Autism Spectrum Disorders.
Prospective longitudinal research continues to be another core area of research (Mannheim Study of Children at Risk). Its continuity along with the increasingly neurobiological and genetic focus contributes substantially to the reputation of CIMH child and adolescent psychiatry department. The research activities are organized within five Research Groups.
Cooperative networks and projects
Research is conducted in close intramural cooperation with the CIMH Departments of Neuropsychology, Genetic Epidemiology, Addiction Medicine and the WG ADHD in Adulthood.
The national cooperations with the CAP departments at the Faculty of Medicine of the Universities of Heidelberg and Ulm were established as a Transregional Center of Competence “Child and Adolescent Psychiatry”, following a recommendation of the Medizin-Struktur-Kommission (MSK; federal governmental board for the evaluation of medical faculties) and funded until 2012. Another national network, in which the CIMH CAP department (TB) is critically involved, is the German ADHD-net (www.zentrales-adhs-netz.de) established on behalf of the German Ministry of Health. It aims at supporting a broad health management for patients of all ages suffering from ADHD and promotes national and international interdisciplinary cooperation.
Furthermore, the CIMH CAP department is building up cooperative research networks with various international partners. Members of the the CAP department are part of the European Network for Hyperkinetic Disorders (Eunethydis), respectively the ADHD Guidelines Group of the Eunethydis.
Tthe CIMH CAP department is also involved in the IMAGEN project, a European-Commission funded international multi-site research project which aims to identify biological and environmental factors that might have an influence on risk taking behaviour and mental health in teenagers.
Moreover, the CIMH CAP department is participating as work package leader in various other EU-funded projects (see below, such as the PERS project (studies with risperidone in conduct disorder and psychotic disorders), STOP project (‘medication-related suicidality’ focusing on the effects of selective serotonin re-uptake inhibitors), ADDUCE project (studies on the long-term safety of stimulant medication for the treatment of ADHD), TACTICS project (focusing on addictive and/or compulsive behaviour in children and adolescents: translating pre-clinical results into therapies).
Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de